Anion exchange protein 3

Anion exchange protein 3 (AE3) is a membrane transport protein encoded by the human SLC4A3 gene.^[5][6]

SLC4A3
Identifiers
Aliases	SLC4A3, AE3, SLC2C, CAE3/BAE3, solute carrier family 4 member 3
External IDs	OMIM: 106195; MGI: 109350; HomoloGene: 129474; GeneCards: SLC4A3; OMA:SLC4A3 - orthologs
Gene location (Human) Chr. Chromosome 2 (human)[1] Band 2q35 Start 219,627,394 bp[1] End 219,641,980 bp[1]
Gene location (Mouse) Chr. Chromosome 1 (mouse)[2] Band 1 C4|1 39.16 cM Start 75,522,910 bp[2] End 75,538,816 bp[2]
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in apex of heart right auricle of heart left ventricle left ovary right ovary myocardium of left ventricle right ventricle nucleus accumbens cardiac muscle tissue of right atrium lateral nuclear group of thalamus Top expressed in perirhinal cortex entorhinal cortex interventricular septum right ventricle myocardium of ventricle cardiac muscles central gray substance of midbrain CA3 field pontine nuclei cingulate gyrus More reference expression data BioGPS More reference expression data
Gene ontology Molecular function antiporter activity inorganic anion exchanger activity anion transmembrane transporter activity sodium:bicarbonate symporter activity Cellular component integral component of membrane integral component of plasma membrane plasma membrane membrane Biological process anion transport regulation of intracellular pH ion transport inorganic anion transport bicarbonate transport transmembrane transport anion transmembrane transport Sources:Amigo / QuickGO
Orthologs Species Human Mouse Entrez 6508 20536 Ensembl ENSG00000114923 ENSMUSG00000006576 UniProt P48751 P16283 RefSeq (mRNA) NM_005070 NM_201574 NM_001326559 NM_009208 NM_001357149 NM_001357150 RefSeq (protein) NP_001313488 NP_005061 NP_963868 NP_033234 NP_001344078 NP_001344079 Location (UCSC) Chr 2: 219.63 – 219.64 Mb Chr 1: 75.52 – 75.54 Mb PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Structure

Cryo-electron microscopy studies have revealed that AE3 forms a homodimeric complex, structurally similar to other members of the SLC4 family, such as AE1 and AE2.^[7] AE3 is stabilized in an outward-facing conformation under resting conditions, contrasting with AE2, which predominantly adopts an inward-facing conformation.^[8] This conformational preference renders AE3 more susceptible to inhibition by DIDS (4,4′-Diisothiocyanatostilbene-2,2′-disulfonic acid), a pan-inhibitor of anion transporters. In addition to its transmembrane domain (TMD), which mediates ion exchange, the soluble N-terminal domain (NTD) of AE3 has also been structurally characterized. A chimeric construct combining the AE3 NTD with the AE2 TMD has provided further insights into domain organization and functional modulation.

Function

AE3 mediates the electroneutral exchange of Cl⁻ and HCO₃⁻, contributing to intracellular pH regulation and bicarbonate homeostasis. It is functionally similar to Band 3 (AE1), but exhibits distinct tissue specificity. AE3 is expressed primarily in brain neurons and cardiac tissue.^[9] Like other members of the SLC4 family, including AE2, AE3 activity is sensitive to changes in intracellular pH, which modulates its transport kinetics.^[10]

Clinical significance

Mutations in the SLC4A3 gene have been associated with neurological and cardiac disorders. Animal models with targeted disruption of AE3 exhibit reduced seizure thresholds, indicating a role for AE3 in neuronal excitability and seizure susceptibility.^[11] A variant of AE3 has also been identified in patients with epilepsy, supporting its involvement in human seizure disorders.^[12] More recently, loss-of-function mutations in SLC4A3 have been linked to Short QT syndrome (SQTS), a rare cardiac channelopathy associated with a high risk of sudden cardiac death.^[13] Subsequent genetic analyses have suggested that SLC4A3 mutations may be one of the most frequent causes of SQTS, underscoring AE3’s importance in cardiac electrophysiology.^[14]

See also

• Solute carrier family